With NMN (Nicotinamide Mononucleotide) now recognized as a leading NAD+ precursor, global demand has surged for high-purity, well-documented bulk raw material. However, differences in quality, storage requirements, and certification can significantly impact product stability and regulatory acceptance. This FAQ-style article addresses the most common questions buyers ask when sourcing NMN at scale.